Recently, Revill et al. showed that DGKI was hypermethylated in primary hepatocellular carcinoma and was re-expressed in liver cancer cell lines after exposure to reagents reversing DNA methylation [18]. The gene discussed is DGKI; the disease is hepatocellular carcinoma.